A study published in JAMA Pediatrics found that antimicrobial resistance in children is increasing globally. The findings suggested that this resistance will accelerate over the next decade and could hinder the effectiveness of life‑saving antibiotics. Antimicrobial resistance occurs when bacteria evolve and become resistant to antibiotic treatment. Pediatric populations are especially vulnerable because children contract higher rates of bacterial infections than adults. Antibiotic treatment options are more limited for youth than adult patients. The collaborative research study included Murdoch Children’s Research Institute (MCRI), Clinton Health Access Initiative (CHAI), the University of Sydney, and The Chinese University of Hong Kong. The findings highlighted the need for child-friendly antibiotic formulations and effective dosing guidance.  

The research team analyzed over 106,000 infection samples from children (18 years or younger) from 82 countries. The researchers discovered that antibiotic resistance increased in every global region between 2004 and 2022. They also found that infants and children in intensive care and countries with fewer healthcare resources were the most vulnerable.

The findings suggested the increase is being driven largely by Gram-negative bacteria that cause severe infections including pneumonia and sepsis. The findings showed significant increases in resistance to critical ‘Watch’ and ‘Reserve’ antibiotics. The World Health Organization (WHO) classifies these antibiotics to minimize overuse and help preserve their effectiveness when first-line treatments fail.

The newly launched AMR in Kids website, created by the study team, allows clinicians, researchers and policymakers to explore antibiotic resistance by country, bacteria and antibiotic class. It also provides region and pathogen-specific forecasts to 2035, helping researchers to identify emerging threats, inform treatment decisions and help guide public health planning.

The research found two types of Gram-negative bacteria associated with increases in global antimicrobial resistance. One type is Acinetobacter baumannii, which frequently causes hospital-acquired bloodstream infections and pneumonia. Acinetobacter baumannii demonstrated the highest overall resistance. The other type is Klebsiella (known for causing liver and urinary tract infections); the study revealed this type increased particularly fast in Eastern Europe, Southeast Asia, and the Western Pacific.

Sources: Eureka News Alert, JAMA Pediatrics